www.fdanews.com/articles/145746-setback-for-novartis-hepatitis-drug
Setback for Novartis Hepatitis Drug
April 19, 2012
Novartis suffered a setback after the U.S. Food and Drug Administration placed the development of an experimental hepatitis treatment on hold following the death of a patient that could be linked to the drug.
The Wall Street Journal
The Wall Street Journal